I agree that this site is using cookies. You can find further informations here.
X
Dent, Ricardo
108  results:
Search for persons X
?
1

Characterizing a Clinical Trial – Representative, Real-Worl..:

Wells, Quinn S ; Farber-Eger, Eric ; Lipworth, Loren...
Clinical Epidemiology.  14 (2022)  - p. 39-49 , 2022
Link: https://doi.org/10.2147/..
 
?
2

Designing, Conducting, Monitoring, and Analyzing Data from ..:

Lentz, Trevor A. ; Curtis, Lesley H. ; Rockhold, Frank W....
Therapeutic Innovation & Regulatory Science.  54 (2020)  6 - p. 1477-1488 , 2020
Link: https://doi.org/10.1007/..
 
?
3

Characteristics and Outcomes of a Real-world Population wit..:

Cohen, Sarah S. ; Farber-Eger, Eric ; Lipworth, Loren...
Journal of Cardiac Failure.  26 (2020)  10 - p. S82 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Willingness to be Reinitiated on a Statin (from the REasons..:

Mefford, Matthew T. ; Tajeu, Gabriel S. ; Tanner, Rikki M....
The American Journal of Cardiology.  122 (2018)  5 - p. 768-774 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Healthcare Utilization and Statin Re‐Initiation Among Medic..:

Booth III, John N. ; Colantonio, Lisandro D. ; Rosenson, Robert S....
Journal of the American Heart Association.  7 (2018)  10 - p. , 2018
Link: https://doi.org/10.1161/..
 
?
6

Why is hypercholesterolaemia so prevalent? A view from evol..:

Laufs, Ulrich ; Dent, Ricardo ; Kostenuik, Paul J...
European Heart Journal.  40 (2018)  33 - p. 2825-2830 , 2018
Link: https://doi.org/10.1093/..
 
?
7

Persistent Safety and Efficacy of Evolocumab in Patients wi..:

Cho, Leslie ; Dent, Ricardo ; Stroes, Erik S.G....
Cardiovascular Drugs and Therapy.  32 (2018)  4 - p. 365-372 , 2018
Link: https://doi.org/10.1007/..
 
?
8

Primary Care Physician Perspectives on Barriers to Statin T..:

Tanner, Rikki M. ; Safford, Monika M. ; Monda, Keri L....
Cardiovascular Drugs and Therapy.  31 (2017)  3 - p. 303-309 , 2017
Link: https://doi.org/10.1007/..
 
?
9

Anti-PCSK9 antibodies for hypercholesterolaemia: Overview o..:

Descamps, Olivier S. ; Fraass, Uwe ; Dent, Ricardo..
International Journal of Clinical Practice.  71 (2017)  8 - p. e12979 , 2017
Link: https://doi.org/10.1111/..
 
?
10

Long-term safety, tolerability, and efficacy of evolocumab ..:

Hovingh, G. Kees ; Raal, Frederick J. ; Dent, Ricardo...
Journal of Clinical Lipidology.  11 (2017)  6 - p. 1448-1457 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Evidence-based goals in LDL-C reduction:

Soran, Handrean ; Dent, Ricardo ; Durrington, Paul
Clinical Research in Cardiology.  106 (2017)  4 - p. 237-248 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Systematic Review and Network Meta‐Analysis on the Efficacy..:

Toth, Peter P. ; Worthy, Gillian ; Gandra, Shravanthi R....
Journal of the American Heart Association.  6 (2017)  10 - p. , 2017
Link: https://doi.org/10.1161/..
 
?
13

Prevention of cardiovascular disease in patients with famil..:

Pećin, Ivan ; Hartgers, Merel L ; Hovingh, G Kees..
European Journal of Preventive Cardiology.  24 (2017)  13 - p. 1383-1401 , 2017
Link: https://doi.org/10.1177/..
 
?
14

Identification and Management of Statin-Associated Symptoms..:

Rosenson, Robert S. ; Gandra, Shravanthi R. ; McKendrick, Jan...
Cardiovascular Drugs and Therapy.  31 (2017)  2 - p. 187-195 , 2017
Link: https://doi.org/10.1007/..
 
?
15

Practical Considerations for the Use of Subcutaneous Treatm..:

Boccara, Franck ; Dent, Ricardo ; Ruilope, Luis.
Advances in Therapy.  34 (2017)  8 - p. 1876-1896 , 2017
Link: https://doi.org/10.1007/..
 
1-15